Hims & Hers Health Newsroom

Citi Maintains Hims & Hers Health(HIMS.US) With Hold Rating, Maintains Target Price $20

Futu NewsOct 4 04:32

B of A Securities Maintains Buy on Hims & Hers Health, Lowers Price Target to $20

BenzingaSep 14 00:53

BofA Securities Maintains Hims & Hers Health(HIMS.US) With Buy Rating, Cuts Target Price to $20

Futu NewsSep 13 19:31

Citi Downgrades Hims & Hers Health(HIMS.US) to Hold Rating, Maintains Target Price $20

Futu NewsAug 27 21:32

Hold Rating on Hims & Hers Health Amid Competitive Threats From Lilly's Zepbound

TipRanksAug 27 20:50

Needham Initiates Hims & Hers Health(HIMS.US) With Buy Rating, Announces Target Price $24

Futu NewsAug 22 19:33

Hims & Hers Health Analyst Ratings

BenzingaAug 22 19:08

Hims & Hers Health (HIMS): A Buy Rating on Strong Growth and Market Positioning

TipRanksAug 22 18:57

Analysts Offer Insights on Healthcare Companies: Hims & Hers Health (HIMS) and RxSight (RXST)

TipRanksAug 20 18:37

BofA Securities Maintains Hims & Hers Health(HIMS.US) With Buy Rating, Maintains Target Price $24

Futu NewsAug 20 18:31

Deutsche Bank Adjusts Hims & Hers Health Price Target to $23 From $16, Maintains Hold Rating

MT NewswiresAug 7 23:55

Leerink Partners Maintains Hims & Hers Health(HIMS.US) With Hold Rating, Cuts Target Price to $21

Futu NewsAug 7 13:31

Hold Rating on Hims & Hers Health Amid Revenue Uptick and Market Uncertainties

TipRanksAug 7 13:29

Seaport Global Maintains Hims & Hers Health(HIMS.US) With Buy Rating, Raises Target Price to $28

Futu NewsAug 7 02:32

Hims & Hers Health Analyst Ratings

BenzingaAug 7 01:52

Piper Sandler Reiterates Neutral on Hims & Hers Health, Maintains $18 Price Target

BenzingaAug 7 01:52

A Quick Look at Today's Ratings for Hims & Hers Health(HIMS.US), With a Forecast Between $18 to $28

Futu NewsAug 6 21:01

Piper Sandler Keeps Their Hold Rating on Hims & Hers Health (HIMS)

TipRanksAug 6 19:28

Hims & Hers Health: Strong Q2 Performance and Positive Outlook Reinforce Buy Rating

TipRanksAug 6 17:27

Hold Rating on Hims & Hers Health Amid GLP-1 Market Uncertainties and Competitive Pressures

TipRanksAug 5 14:20